PeerBasis
Health Care · NY

Drugs For Neglected Diseases Initiative

Drugs For Neglected Diseases Initiative reported paying Delali Attipoe, Executive Director, $310,984 in total compensation (FY 2024).

That places Delali Attipoe at approximately the 83rd percentile among 1129 similarly sized health care nonprofits (median $176,806).

$6,221,917Total revenue (FY 2024)
$310,984Total executive compensation
83rdPercentile vs. peers

Setting executive pay for this board?

Generate a board-ready comparability report for Drugs For Neglected Diseases Initiative — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.

Build the comparability report →

Comparable health care nonprofits

Compensation is normalized to NY cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.

OrganizationStateRevenueTotal comp
Morselife Hospice Institute Inc FL$6,224,615 $281,813
Douglas Gardens Home Care Inc FL$6,216,780 $32,594
American Telemedicine Association DC$6,228,882 $362,611
D'youville Transitional Care Inc MA$6,229,057 $26,930
Jessica And Friends Community PA$6,232,112 $101,743
Mmc Realty Corp ME$6,210,813 $126,716
Prairie Manor Inc MN$6,233,624 $101,833
Transitions At Home Inc CO$6,208,769 $144,093

View original IRS filings on ProPublica →